Scientists Demonstrate Utility of Bilateral Tumor Model for Evaluating Anti-Cancer T-cell Responses
Scientists demonstrate that a bilateral tumor model could be useful to investigate the relationship between T-cell repertoire and the…
Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection
First and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the…
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
T-Detect is currently under review by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA)…